Effects of low- or high-dose hormone therapy on fasting and post-methionine homocysteine levels in postmenopausal women

Climacteric

Volumn 9, Issue 5, 2006, Pages 388-395

  Cagnacci, A ^a   Generali, M ^a   Pirillo, D ^a   Baldassari, F ^a   Volpe, A ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Estrogen; Homocysteine; Hormone therapy; Menopause; Methionine; Progestogen

Indexed keywords

ESTRADIOL PLUS NORETHISTERONE ACETATE; FOLIC ACID; HOMOCYSTEINE; HORMONE DERIVATIVE; METHIONINE;

ADULT; ARTICLE; CALCIUM INTAKE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HORMONE SUBSTITUTION; HUMAN; LOW DRUG DOSE; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; THROMBOEMBOLISM;

DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FASTING; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; METHIONINE; MIDDLE AGED; NORETHINDRONE; POSTMENOPAUSE; PROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; VITAMIN B 12;

EID: 33749018803     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.1080/13697130600870352     Document Type: Article

References (40)

1. Mudd SH, Levy HL. Disorders in transsulfuration. In Stanbury JB, Wyngaaden JB, Fredrickson DS, Goldstein JL, Brown MS, eds. Metabolic Bases of Inherited Disease, 5th edn. New York: McGraw-Hill, 1995:1279-327
2. Moustapha A, Robinson K. Homocysteine: an emerging age-related cardiovascular risk factor. Geriatrics 1995;54:49-63
3. Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 1993;39:1764-79
4. Aguilar B, Rojas JC, Collados MT. Metabolism of homocysteine and its relationship with cardiovascular disease. J Thromb Thrombolysis 2004;18:75-87
5. Graham IM, Daly LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease. JAMA 1997;277:1775-81
6. Cattaneo M, Martinelli I, Mannucci PM. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 1996;335:974-6
7. Selhub J, Jacques PF, Wilson PWF, Rush D, Rosemberg IH. Vitamin status and intake as a primary determinant of homocysteine in the elderly. JAMA 1993;270:2693-8
8. Brattstrom L, Lindgren A, Israelsson B, Andersson A, Hultberg B. Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects. J Intern Med 1994;236:633-41
9. Jacobsen DW, Gatautis VJ, Green R, et al. Rapid HPLC determination of total homocysteine and other thiols in serum and plasma: sex differences and correlation with cobalamin and folate concentrations in healthy subjects. Clin Chem 1994;40:873-81
10. Wouters MG, Moorrees MT, van der Mooren MJ, et al. Plasma homocysteine and menopausal status. Eur J Clin Invest 1995;25:801-15
11. Hak AE, Polderman KH, Westendorp IC, et al. Increased plasma homocysteine after menopause. Atherosclerosis 2000;149:163-8
12. van der Mooren MJ, Wouters MG, Blom HJ, Schellekens LA, Eskes TK, Rolland R. Hormone replacement therapy may reduce high serum homocysteine in postmenopausal women. Eur J Clin Invest 1994;24:733-6
13. Barnabei VM, Phillips TM, Hsia J. Plasma homocysteine in women taking hormone replacement therapy: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. J Womens Health Gend Based Med 1999;8:1167-72
14. Van Baal WM, Smolders RG, van der Mooren MJ, Teerlink T, Kenemans P. Hormone replacement therapy and plasma homocysteine levels. Obstet Gynecol 1999;94:485-91
15. Walsh BW, Paul S, Wild RA, Tracy RP, Cox DA, Anderson PW. The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial. J Clin Endocrinol Metab 2000;85:214-18
16. Mijatovic V, Kenemans P, Netelenbos C, et al. Postmenopausal oral 17β-estradiol continuously combined with dydrogesterone reduces fasting serum homocysteine levels. Fertil Steril 1998;69:876-82
17. Mijatovic V, Kenemans P, Jakobs C, van Baal WM, Peters-Muller ER, van der Mooren MJ. A randomized controlled study of the effects of 17beta-estradiol- dydrogesterone on plasma homocysteine in postmenopausal women. Obstet Gynecol 1998;91:432-46
18. Chiantera V, Sarti CD, Fornaro F, et al. Long-term effects of oral and transdermal hormone replacement therapy on plasma homocysteine levels. Menopause 2003;10:286-91
19. Cagnacci A, Malmusi S, Zanni AL, Alessandrini C, Caretto S, Volpe A. Comparison of the effect of oral and transdermal hormone therapy on fasting and postmethionine homocysteine levels. Fertil Steril 2004;81:99-103
20. Berger PB, Herrmann RR, Dumesic DA. The effect of estrogen replacement therapy on total plasma homocysteine in healthy postmenopausal women. Mayo Clin Proc 2000;75:18-23
21. Ventura P, Cagnacci A, Malmusi S, et al. Continuous combined hormone replacement therapy with oral 17 beta-estradiol and norethisterone acetate improves homocysteine metabolism in postmenopausal women. Menopause 2001;8:252-8
22. Smolders RG, de Meer K, Kenemans P, Teerlink T, Jakobs C, van der Mooren MJ. Hormone replacement influences homocysteine levels in the methionine-loading test: a randomized placebo controlled trial in postmenopausal women. Eur J Obstet Gynecol Reprod Biol 2004;117:55-9
23. Tutuncu L, Ergur AR, Mungen E, Gun I, Ertekin A, Yergok YZ. The effect of hormone therapy on plasma homocysteine levels: a randomized clinical trial. Menopause 2005;12:216-22
24. Stampfer MJ, Willett WC, Colditz GA, Rosner B, Speizer FE, Hennekens CH. A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med 1985;313:1044-9
25. Grady D, Rubin SM, Petitti DB, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992;117:1016-37
26. Grodstein F, Manson JE, Colditz GA, Willett WC, Speizer FE, Stampfer MJ. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med 2000;133:933-41
27. Grady D, Herrington D, Bittner V, et al. HERS Research Group. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 2002;288:49-57
28. Rossouw JE, Anderson GL, Prentice RL, et al. Writing Group for the Women's Health Initiative Investigators Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33
29. Cornwell PE, Morgan SL, Vaughn WH. Modification of a high performance liquid chromatographic method for assay of homocysteine in human plasma. J Chromatogr B 1993;617:136-9
30. Dankner R, Chetrit A, Lubin F, Sela BA. Life-style habits and homocysteine levels in an elderly population. Aging Clin Exp Res 2004;16:437-42
31. Evio S, Tiitinen A, Turpeinen U, Ylikorkala O. Failure of the combination of sequential oral and transdermal estradiol plus norethisterone acetate to affect plasma homocysteine levels. Fertil Steril 2000;74:1080-3
32. Melse-Boonstra A, Holm PI, Ueland PM, Olthof M, Clarke R, Verhoef P. Betaine concentration as a determinant of fasting total homocysteine concentrations and the effect of folic acid supplementation on betaine concentrations. Am J Clin Nutr 2005;81:1378-82
33. Jencks DA, Mathews RG. Allosteric inhibition of methylenetetrahydrofolate reductase by adenosylmethionine. Effects of adenosylmethionine and NADPH on the equilibrium between active and inactive forms of the enzyme and on the kinetics of approach to equilibrium. J Biol Chem 1987;262:2485-93
34. Finkelstein JD, Kyle WE, Martin JL, Pick AM. Activation of cystathionine synthase by adenosylmethionine and adenosylethionine. Biochem Biophys Res Commun 1975;66:81-7
35. Finkelstein JD. The metabolism of homocysteine: pathways and regulation. Eur J Pediatr 1998;157(Suppl 2):S40-4
36. Lee GR, Herbert V. Nutritional factors in the production and function of erythrocytes. In Lee GR, Foerster J, Lukens J, Paraskevas F, Greer JP, Rodgers GM, eds. Wintrobes's Clinical Hematology, 10th edn. Baltimore: Williams & Wilkins, 1999:228-66
37. Carmel R. R binder deficiency. A clinical benign cause of cobalamin pseudodeficiency. JAMA 1983;250:1886-90
38. Hakami N, Neimann P, Canellos GP, Lazerson J. Neonatal megaloblastic anemia due to inherited transcobalamin II deficiency in two siblings. N Engl J Med 1971;285:1163-70
39. Gardyn J, Mittelman M, Zlotnik J, Sela BA, Cohen AM. Oral contraceptives can cause falsely low vitamin B (12) levels. Acta Haematol 2000;104:22-4
40. Shojania AM, Wylie B. The effect of oral contraceptives agents on vitamin B12 metabolism. Am J Obstet Gynecol 1979;135:129-34